Carcinoma, Non-Small-Cell Lung  >>  pentamidine oral (VLX103)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
pentamidine oral (VLX103) / Odan Labs
NCT01844791 / 2012-001812-50: An Exploratory Study of OCZ103-OS in Combination With Standard of Care in Stage IV Non-Small Cell Lung Cancer (NSCLC) Patients

Completed
2a
25
Europe
OCZ103-OS, pentamidine bis(2-hydroxyethanesulfonate, Platinum, Gemcitabine
Oncozyme Pharma Inc.
Non-small Cell Lung Cancer
01/14
01/14

Download Options